Akreos MI60 to be available in Korea

Published: 2008-06-10 06:52:00

Updated: 2008-06-10 06:52:00

Bausch & Lomb Korea, the Korean unit of Bausch & Lomb, says it has received a marketing approval of its Akreos AO Micro Incision Intraocular Lens (Akreos MI60).

In keeping with Bausch & Lomb’s drive for smaller cataract incisions and ever better patient outcomes, the innovative Akreos MI60 int...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK